Express Scripts (ESRX +3.3%) completes its $29.1B purchase of Medco (MHS -1.3%) following the FTC's approval of the deal. Three senior Medco execs will join Express' top team, although that doesn't incldue Medco CEO David Snow. Despite its dispute with Express, Walgreen's (WAG +2.3%) contract with Medco will be honored.